Skip to main content

Table 5 Postoperative laboratory data during the first 3 postoperative days

From: Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

 

Remifentanil (n = 47)

Dexmedetomidine (n = 47)

P

Peak AST (U/L)

293.15 ± 208.68

285.98 ± 131.67

0.843

Peak ALT (U/L)

240.48 ± 196.20

265.17 ± 207.06

0.557

Nadir ALB (g/L)

34.62 ± 5.44

32.92 ± 6.82

0.190

Peak TBIL (μmol/L)

42.32 ± 30.97

49.21 ± 55.05

0.468

Peak PT (s)

17.06 ± 6.26

16.23 ± 5.12

0.522

Nadir PT% activity

71.72 ± 12.68

73.54 ± 13.29

0.540

  1. Values are expressed as mean ± standard deviation
  2. ALT alanine aminotransferase, AST aspartate aminotransferase, ALB albumin, TBIL total bilirubin, PT prothrombin time